anti-IgE monoclonal half antibody (Sixal Corporation)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-IgE monoclonal half antibody (Sixal Corporation)
Drug Alias Name[AEHM] E-3.56
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSixal Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSixal Corp
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A